Skip to main content
logo
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
168.51
-3.28 (-1.91%)
At close: Apr 2, 2026, 4:00 PM EDT
170.26
+1.76 (1.04%)
After-hours: Apr 2, 2026, 7:05 PM EDT

Axsome Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-183.17-287.22-239.24-187.13-130.4
Depreciation & Amortization
9.067.966.834.40.08
Stock-Based Compensation
93.7585.2262.6237.7320.8
Other Adjustments
9.4831.7353.14.830.97
Change in Receivables
-82.46-47.18-57.12-37.7-
Changes in Inventories
-10.660.74-8.16-1.33-
Changes in Accounts Payable
-6.4631.322.0725.46-0.36
Changes in Accrued Expenses
83.7456.0736.4543.920.58
Changes in Other Operating Activities
-6.68-7.05-1.64-6.680.1
Operating Cash Flow
-93.41-128.41-145.08-116.51-108.23
Capital Expenditures
-0.48-0.27-0.58-0.7-0.31
Payments for Business Acquisitions
----53-
Investing Cash Flow
-0.48-0.27-0.58-53.7-0.31
Long-Term Debt Issued
330-8545-
Long-Term Debt Repaid
-331.99----
Net Long-Term Debt Issued (Repaid)
-1.99-8545-
Issuance of Common Stock
127.4671.46271.17250.0111.84
Repurchase of Common Stock
-7.11-3.95-1.84-0.53-0.18
Net Common Stock Issued (Repurchased)
120.3567.51269.33249.4811.66
Other Financing Activities
-16.9-9.67-23.32-9.9-0.53
Financing Cash Flow
101.4757.84331.01284.5811.13
Net Cash Flow
7.58-70.84185.35114.37-97.4
Free Cash Flow
-93.89-128.68-145.66-117.21-108.53
FCF Margin
-14.70%-33.36%-53.83%-234.25%-
Free Cash Flow Per Share
-1.89-2.69-3.21-2.88-2.89
Levered Free Cash Flow
-116.64-198.45-119.26-77.07-130.31
Unlevered Free Cash Flow
-97.76-191.88-197.78-114.73-124.62
Updated Feb 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q